Skip to main content
Gilead Sciences, Inc. (ETR:GIS)
Germany flag Germany · Delayed Price · Currency is EUR
94.18
+2.66 (2.91%)
Jun 27, 2025, 5:35 PM CET

Gilead Sciences Revenue

Gilead Sciences had revenue of $6.67B USD in the quarter ending March 31, 2025, a decrease of -0.28%. This brings the company's revenue in the last twelve months to $28.74B, up 4.68% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.75B with 6.04% growth.

Revenue (ttm)
$28.74B
Revenue Growth
+4.68%
P/S Ratio
4.42
Revenue / Employee
$1.63M
Employees
17,600
Market Cap
117.50B EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202428.75B1.64B6.04%
Dec 31, 202327.12B-165.00M-0.60%
Dec 31, 202227.28B-24.00M-0.09%
Dec 31, 202127.31B2.62B10.60%
Dec 31, 202024.69B2.24B9.98%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 23.14B
Merck KGaA 21.32B
Bayer Aktiengesellschaft 46.58B
Fresenius SE & Co. KGaA 22.13B
Fresenius Medical Care AG 19.49B
Sartorius Aktiengesellschaft 3.44B
Carl Zeiss Meditec AG 2.17B
Fielmann Group AG 2.33B
Revenue Rankings

Gilead Sciences News

More News